Provided by Tiger Fintech (Singapore) Pte. Ltd.

Castle Biosciences, Inc.

18.57
-0.6200-3.23%
Post-market: 18.570.00000.00%17:55 EDT
Volume:459.52K
Turnover:8.47M
Market Cap:529.51M
PE:29.95
High:18.99
Open:18.51
Low:17.90
Close:19.19
Loading ...

Castle Biosciences price target raised to $40 from $34 at Lake Street

TIPRANKS
·
05 Nov 2024

Castle Biosciences Inc : Scotiabank Raises Target Price to $44 From $37

THOMSON REUTERS
·
05 Nov 2024

Castle Biosciences (CSTL) Gets a Buy from Lake Street

TIPRANKS
·
05 Nov 2024

Castle Biosciences Is Maintained at Overweight by Keybanc

Dow Jones
·
05 Nov 2024

Castle Biosciences Inc reports results for the quarter ended in September 30 - Earnings Summary

Reuters
·
05 Nov 2024

Castle Biosciences, Inc. (CSTL) Tops Q3 Earnings and Revenue Estimates

Zacks
·
05 Nov 2024

Stock Track | Castle Biosciences Surges After Smashing Q3 Earnings Estimates

Stock Track
·
05 Nov 2024

Castle Biosciences Q3 2024 GAAP EPS $0.08 Beats $(0.03) Estimate, Sales $85.800M Beat $79.842M Estimate

Benzinga
·
05 Nov 2024

Castle Biosciences Inc FY2024 REV View $298.0 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
05 Nov 2024

Castle Biosciences Inc: Raising Full-Year 2024 Revenue Guidance to $320-330 Mln

THOMSON REUTERS
·
05 Nov 2024

Castle Biosciences, Inc. (CSTL) Hit a 52 Week High, Can the Run Continue?

Zacks
·
01 Nov 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
01 Nov 2024

Castle Biosciences to present new TissueCypher data at ACG 2024

TIPRANKS
·
30 Oct 2024

Liquidia Technologies, Inc. (LQDA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Zacks
·
29 Oct 2024

Castle Biosciences Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
29 Oct 2024

Starboard Slams Pfizer for R&D Inefficiencies, Overpaid Acquisitions

Zacks
·
24 Oct 2024

Here's Why Momentum in Castle Biosciences (CSTL) Should Keep going

Zacks
·
23 Oct 2024

Castle Biosciences, Inc. (CSTL) is a Great Momentum Stock: Should You Buy?

Zacks
·
23 Oct 2024

Castle Biosciences Says Data Shows Efficacy of its Skin Cancer Tests

MT Newswires Live
·
21 Oct 2024

AbbVie Secures FDA Approval for Parkinson's Disease Drug Vyalev

Zacks
·
18 Oct 2024